Atif Masood Noori Muhammad, Rushdy Abanoub, Fichadiya Hardik, Sherif Roman, Younes Islam, Lenchur Peter D, Lenchur Peter M, Shamoon Fayaz
Department of Medicine, Rutgers New Jersey Medical School, Elizabeth, NJ, USA.
Department of Cardiology, St. Joseph's University Medical Center, Paterson, NJ, USA.
J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):769-771. doi: 10.1080/20009666.2021.1980964. eCollection 2021.
Since the beginning of the coronavirus disease 2019 (COVID19) pandemic, several cases of myocarditis related to COVID-19 infection have been reported. These cases range from asymptomatic disease to fulminant heart failure or sudden cardiac death. Cardiac injury has also been found in asymptomatic patients and patients who recovered from the disease. Data regarding cardiovascular involvement due to COVID-19 infection are still limited, and the actual prevalence of myocarditis due to COVID-19 infection is still unknown. We present a case of focal myopericarditis in a patient recently recovered from COVID-19 pneumonia with electrocardiogram showing ST elevation in inferior and lateral leads. This case highlights the need for studying the long-term cardiovascular complications of COVID-19 and reinforces the use of cardiac magnetic resonance (CMR) and cardiac biomarkers in the diagnosis of COVID-19-related myocarditis.
自2019冠状病毒病（COVID-19）大流行开始以来，已有多例与COVID-19感染相关的心肌炎病例报告。这些病例范围从无症状疾病到暴发性心力衰竭或心源性猝死。在无症状患者以及从该疾病中康复的患者中也发现了心脏损伤。关于COVID-19感染所致心血管受累的数据仍然有限，且COVID-19感染所致心肌炎的实际患病率仍不清楚。我们报告一例近期从COVID-19肺炎康复的患者发生局灶性心肌心包炎，其心电图显示下壁和侧壁导联ST段抬高。该病例凸显了研究COVID-19长期心血管并发症的必要性，并强化了心脏磁共振成像（CMR）和心脏生物标志物在诊断COVID-19相关心肌炎中的应用。
